Supplemental material
Future Oncology
Volume 16, 2020 - Issue 15
Open access
33,667
Views
127
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol
IMbrave 050: A Phase III Trial of Atezolizumab Plus Bevacizumab in High-Risk Hepatocellular Carcinoma after Curative Resection or Ablation
Stephen P Hack1 Genentech, Inc,1 DNA Way,South San Francisco,CA94080,USACorrespondence[email protected]
https://orcid.org/0000-0002-0640-5709View further author information
, https://orcid.org/0000-0002-0640-5709View further author information
Jessica Spahn1 Genentech, Inc,1 DNA Way,South San Francisco,CA94080,USAView further author information
, Minshan Chen2 Department of Hepatobiliary Surgery,Cancer Centre of Sun Yat-sen University,Guangzhou,PR ChinaView further author information
, Ann-Lii Cheng3 National Taiwan University Cancer Center & National Taiwan University Hospital,Taipei,TaiwanView further author information
, Ahmed Kaseb4 Department of Gastrointestinal Medical Oncology,The University of Texas MD Anderson Cancer Center,Houston,TX77030,USAView further author information
, Masatoshi Kudo5 Department of Gastroenterology & Hepatology,Kindai University School of Medicine,Osaka,JapanView further author information
, Han Chu Lee6 Department of Internal Medicine, Asan Medical Center,University of Ulsan College of Medicine,Seoul,Republic of KoreaView further author information
, Adam Yopp7 Department of Surgery, Division of Surgical Oncology,University of Texas Southwestern Medical Center,Dallas,TX75390,USAView further author information
, Pierce Chow8 Division of Surgical Oncology,National Cancer Centre,SingaporeView further author information
& Shukui Qin9 PLA Cancer Center,People’s Liberation Army (PLA) 81 Hospital,Nanjing210016,PR ChinaView further author information
show all
Pages 975-989
|
Received 25 Feb 2020, Accepted 19 Mar 2020, Published online: 30 Apr 2020
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.